Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Ocean Bio-Chem

Nasdaq:OBCI
Snowflake Description

Excellent balance sheet and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
OBCI
Nasdaq
$43M
Market Cap
  1. Home
  2. US
  3. Household
Company description

Ocean Bio-Chem, Inc. manufactures, markets, and distributes appearance, performance, and maintenance products for the marine, automotive, power sports, recreational vehicle, and outdoor power equipment markets in the United States and Canada. The last earnings update was 138 days ago. More info.


Add to Portfolio Compare Print
OBCI Share Price and Events
7 Day Returns
16%
NasdaqCM:OBCI
11.1%
US Household Products
12.5%
US Market
1 Year Returns
38.6%
NasdaqCM:OBCI
4.6%
US Household Products
-12.7%
US Market
OBCI Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Ocean Bio-Chem (OBCI) 16% -8.8% 37.8% 38.6% 3.4% 12.6%
US Household Products 11.1% -2.8% -10.9% 4.6% 20.3% 34%
US Market 12.5% -14.7% -21.5% -12.7% 5.4% 17.5%
1 Year Return vs Industry and Market
  • OBCI outperformed the Household Products industry which returned 4.6% over the past year.
  • OBCI outperformed the Market in United States of America which returned -12.7% over the past year.
Price Volatility
OBCI
Industry
5yr Volatility vs Market

OBCI Value

 Is Ocean Bio-Chem undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Ocean Bio-Chem to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Ocean Bio-Chem.

NasdaqCM:OBCI Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 6.1%
Perpetual Growth Rate 10-Year US Government Bond Rate 1.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NasdaqCM:OBCI
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 1.7%
Equity Risk Premium S&P Global 5.4%
Household Products Unlevered Beta Simply Wall St/ S&P Global 0.39
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.388 (1 + (1- 21%) (11.63%))
0.614
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.8
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.74% + (0.8 * 5.44%)
6.09%

Discounted Cash Flow Calculation for NasdaqCM:OBCI using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Ocean Bio-Chem is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

NasdaqCM:OBCI DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 6.09%)
2020 1.84 Est @ 27.29% 1.73
2021 2.20 Est @ 19.63% 1.95
2022 2.51 Est @ 14.26% 2.11
2023 2.78 Est @ 10.5% 2.19
2024 3.00 Est @ 7.87% 2.23
2025 3.18 Est @ 6.03% 2.23
2026 3.33 Est @ 4.75% 2.20
2027 3.46 Est @ 3.84% 2.15
2028 3.57 Est @ 3.21% 2.10
2029 3.67 Est @ 2.77% 2.03
Present value of next 10 years cash flows $20.00
NasdaqCM:OBCI DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $3.67 × (1 + 1.74%) ÷ (6.09% – 1.74%)
$85.72
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $85.72 ÷ (1 + 6.09%)10
$47.45
NasdaqCM:OBCI Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $20.00 + $47.45
$67.45
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $67.45 / 9.45
$7.14
NasdaqCM:OBCI Discount to Share Price
Calculation Result
Value per share (USD) From above. $7.14
Current discount Discount to share price of $4.56
= -1 x ($4.56 - $7.14) / $7.14
36.1%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Ocean Bio-Chem is available for.
Intrinsic value
36%
Share price is $4.56 vs Future cash flow value of $7.14
Current Discount Checks
For Ocean Bio-Chem to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Ocean Bio-Chem's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Ocean Bio-Chem's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Ocean Bio-Chem's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Ocean Bio-Chem's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqCM:OBCI PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in USD $0.29
NasdaqCM:OBCI Share Price ** NasdaqCM (2020-03-30) in USD $4.56
United States of America Household Products Industry PE Ratio Median Figure of 8 Publicly-Listed Household Products Companies 25.82x
United States of America Market PE Ratio Median Figure of 2,942 Publicly-Listed Companies 12.96x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Ocean Bio-Chem.

NasdaqCM:OBCI PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqCM:OBCI Share Price ÷ EPS (both in USD)

= 4.56 ÷ 0.29

15.66x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Ocean Bio-Chem is good value based on earnings compared to the US Household Products industry average.
  • Ocean Bio-Chem is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does Ocean Bio-Chem's expected growth come at a high price?
Raw Data
NasdaqCM:OBCI PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 15.66x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Household Products Industry PEG Ratio Median Figure of 6 Publicly-Listed Household Products Companies 4.32x
United States of America Market PEG Ratio Median Figure of 2,006 Publicly-Listed Companies 0.99x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Ocean Bio-Chem, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Ocean Bio-Chem's assets?
Raw Data
NasdaqCM:OBCI PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in USD $3.19
NasdaqCM:OBCI Share Price * NasdaqCM (2020-03-30) in USD $4.56
United States of America Household Products Industry PB Ratio Median Figure of 12 Publicly-Listed Household Products Companies 2.68x
United States of America Market PB Ratio Median Figure of 5,143 Publicly-Listed Companies 1.26x
NasdaqCM:OBCI PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqCM:OBCI Share Price ÷ Book Value per Share (both in USD)

= 4.56 ÷ 3.19

1.43x

* Primary Listing of Ocean Bio-Chem.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Ocean Bio-Chem is good value based on assets compared to the US Household Products industry average.
X
Value checks
We assess Ocean Bio-Chem's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Household Products industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Household Products industry average (and greater than 0)? (1 check)
  5. Ocean Bio-Chem has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

OBCI Future Performance

 How is Ocean Bio-Chem expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ocean Bio-Chem has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
11.4%
Expected Household Products industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Ocean Bio-Chem expected to grow at an attractive rate?
  • Unable to compare Ocean Bio-Chem's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Ocean Bio-Chem's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare Ocean Bio-Chem's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
NasdaqCM:OBCI Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Household Products Industry Earnings Growth Rate Market Cap Weighted Average 11.4%
United States of America Household Products Industry Revenue Growth Rate Market Cap Weighted Average 3.1%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 12.3%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqCM:OBCI Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqCM:OBCI Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
NasdaqCM:OBCI Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-09-30 41 4 3
2019-06-30 42 2 3
2019-03-31 42 0 3
2018-12-31 42 1 3
2018-09-30 42 2 3
2018-06-30 40 2 3
2018-03-31 38 3 3
2017-12-31 38 3 3
2017-09-30 38 3 3
2017-06-30 39 3 3
2017-03-31 38 3 3
2016-12-31 36 3 2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Ocean Bio-Chem is high growth as no earnings estimate data is available.
  • Unable to determine if Ocean Bio-Chem is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqCM:OBCI Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Ocean Bio-Chem Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:OBCI Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
NasdaqCM:OBCI Past Financials Data
Date (Data in USD Millions) EPS *
2019-09-30 0.29
2019-06-30 0.31
2019-03-31 0.32
2018-12-31 0.30
2018-09-30 0.35
2018-06-30 0.30
2018-03-31 0.28
2017-12-31 0.28
2017-09-30 0.30
2017-06-30 0.38
2017-03-31 0.35
2016-12-31 0.23

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Ocean Bio-Chem will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine whether Ocean Bio-Chem is trading at Ocean Bio-Chem'san attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
  2. Ocean Bio-Chem's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Household companies here
  3. Ocean Bio-Chem's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Ocean Bio-Chem's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Ocean Bio-Chem has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

OBCI Past Performance

  How has Ocean Bio-Chem performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Ocean Bio-Chem's growth in the last year to its industry (Household Products).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Ocean Bio-Chem's year on year earnings growth rate has been positive over the past 5 years.
  • Ocean Bio-Chem's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Ocean Bio-Chem's 1-year earnings growth is negative, it can't be compared to the US Household Products industry average.
Earnings and Revenue History
Ocean Bio-Chem's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Ocean Bio-Chem Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:OBCI Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 41.36 2.73 10.96
2019-06-30 42.04 2.88 10.85
2019-03-31 42.50 2.99 10.85
2018-12-31 41.80 2.80 10.69
2018-09-30 41.73 3.21 10.83
2018-06-30 39.88 2.79 10.55
2018-03-31 38.10 2.62 10.03
2017-12-31 37.94 2.60 9.96
2017-09-30 37.70 2.76 9.65
2017-06-30 38.57 3.44 9.78
2017-03-31 37.68 3.14 9.75
2016-12-31 36.21 2.10 9.63
2016-09-30 36.09 1.71 9.55
2016-06-30 34.72 0.48 9.40
2016-03-31 34.74 -0.06 9.55
2015-12-31 33.99 0.46 9.42
2015-09-30 34.34 0.90 9.43
2015-06-30 33.93 1.51 9.15
2015-03-31 34.01 1.81 9.23
2014-12-31 33.93 2.05 8.98
2014-09-30 32.94 1.85 8.82
2014-06-30 32.95 1.57 8.75
2014-03-31 32.31 1.34 8.60
2013-12-31 32.70 1.46 8.58
2013-09-30 31.82 1.61 8.29
2013-06-30 31.64 1.76 8.19

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Ocean Bio-Chem has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Ocean Bio-Chem used its assets less efficiently than the US Household Products industry average last year based on Return on Assets.
  • Ocean Bio-Chem's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Ocean Bio-Chem's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Household Products industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Ocean Bio-Chem has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

OBCI Health

 How is Ocean Bio-Chem's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Ocean Bio-Chem's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Ocean Bio-Chem is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Ocean Bio-Chem's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Ocean Bio-Chem's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Ocean Bio-Chem Company Filings, last reported 6 months ago.

NasdaqCM:OBCI Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 30.08 4.61 2.11
2019-06-30 28.72 5.11 1.11
2019-03-31 27.70 4.81 0.56
2018-12-31 27.43 4.91 1.40
2018-09-30 27.56 7.76 1.84
2018-06-30 26.00 5.26 0.92
2018-03-31 24.86 4.22 2.29
2017-12-31 24.90 4.27 2.42
2017-09-30 24.58 5.33 1.32
2017-06-30 23.44 0.04 0.87
2017-03-31 23.02 0.15 3.40
2016-12-31 22.52 0.26 4.07
2016-09-30 22.07 0.37 1.09
2016-06-30 20.24 0.48 1.80
2016-03-31 19.59 0.59 2.44
2015-12-31 20.64 0.69 2.47
2015-09-30 20.58 0.80 0.93
2015-06-30 20.12 0.90 2.85
2015-03-31 20.01 1.01 2.01
2014-12-31 20.03 1.11 3.06
2014-09-30 19.53 1.21 1.83
2014-06-30 18.85 1.31 2.71
2014-03-31 18.11 1.41 2.83
2013-12-31 18.27 1.51 3.07
2013-09-30 17.96 1.91 0.68
2013-06-30 17.24 1.71 1.01
  • Ocean Bio-Chem's level of debt (15.3%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (6.2% vs 15.3% today).
  • Debt is well covered by operating cash flow (86%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 26.2x coverage).
X
Financial health checks
We assess Ocean Bio-Chem's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Ocean Bio-Chem has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

OBCI Dividends

 What is Ocean Bio-Chem's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
1.1%
Current annual income from Ocean Bio-Chem dividends.
If you bought $2,000 of Ocean Bio-Chem shares you are expected to receive $22 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Ocean Bio-Chem's pays a lower dividend yield than the bottom 25% of dividend payers in United States of America (1.98%).
  • Ocean Bio-Chem's dividend is below the markets top 25% of dividend payers in United States of America (5.49%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqCM:OBCI Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Household Products Industry Average Dividend Yield Market Cap Weighted Average of 8 Stocks 2.6%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1946 Stocks 3%
United States of America Minimum Threshold Dividend Yield 10th Percentile 1.1%
United States of America Bottom 25% Dividend Yield 25th Percentile 2%
United States of America Top 25% Dividend Yield 75th Percentile 5.5%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NasdaqCM:OBCI Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
NasdaqCM:OBCI Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2019-11-14 0.050 1.387
2019-08-14 0.050 1.476
2019-03-26 0.050 1.504
2018-11-14 0.060 1.694
2018-08-14 0.060 1.489
2018-05-15 0.060 1.654
2018-04-02 0.060 1.734
2017-11-14 0.060 1.480
2017-04-17 0.060 1.359

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Ocean Bio-Chem has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).
  • Ocean Bio-Chem has only been paying a dividend for 3 years, and since then dividends per share have fallen.
Current Payout to shareholders
What portion of Ocean Bio-Chem's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Ocean Bio-Chem has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Ocean Bio-Chem's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Ocean Bio-Chem afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Ocean Bio-Chem has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

OBCI Management

 What is the CEO of Ocean Bio-Chem's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Peter Dornau
COMPENSATION $312,073
AGE 79
TENURE AS CEO 47.2 years
CEO Bio

Mr. Peter G. Dornau co-founded Ocean Bio-Chem Inc. and has been its Chief Executive Officer, President, Chairman and Director since 1973.

CEO Compensation
  • Peter's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Peter's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Ocean Bio-Chem management team in years:

15.5
Average Tenure
62.5
Average Age
  • The average tenure for the Ocean Bio-Chem management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Peter Dornau

TITLE
Co-Founder
COMPENSATION
$312K
AGE
79
TENURE
47.2 yrs

Jeffrey Barocas

TITLE
CFO, VP of Finance & Director
COMPENSATION
$267K
AGE
71
TENURE
13 yrs

William Dudman

TITLE
COO, VP
COMPENSATION
$264K
AGE
54
TENURE
15.8 yrs

Greg Dornau

TITLE
Executive VP of Sales & Marketing & Director
COMPENSATION
$286K
AGE
50
TENURE
15.2 yrs

Anca Vague

TITLE
Controller of Financial Reporting
Board of Directors Tenure

Average tenure and age of the Ocean Bio-Chem board of directors in years:

12.6
Average Tenure
61
Average Age
  • The average tenure for the Ocean Bio-Chem board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

Peter Dornau

TITLE
Co-Founder
COMPENSATION
$312K
AGE
79
TENURE
47.2 yrs

Jeffrey Barocas

TITLE
CFO, VP of Finance & Director
COMPENSATION
$267K
AGE
71
TENURE
12.6 yrs

William Dudman

TITLE
COO, VP
COMPENSATION
$264K
AGE
54
TENURE
12.6 yrs

Greg Dornau

TITLE
Executive VP of Sales & Marketing & Director
COMPENSATION
$286K
AGE
50
TENURE
12.6 yrs

Diana Conard

TITLE
Independent Director
COMPENSATION
$7K
AGE
48
TENURE
8.8 yrs

James Kolisch

TITLE
Director
COMPENSATION
$5K
AGE
68
TENURE
21.8 yrs

John Turner

TITLE
Independent Director
COMPENSATION
$7K
AGE
72
TENURE
19.7 yrs

Kim Krause

TITLE
Independent Director
COMPENSATION
$6K
AGE
49
TENURE
3.7 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess Ocean Bio-Chem's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Ocean Bio-Chem has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

OBCI News

Simply Wall St News

Read This Before You Buy Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Because Of Its P/E Ratio

We'll apply a basic P/E ratio analysis to Ocean Bio-Chem, Inc.'s (NASDAQ:OBCI), to help you decide if the stock is worth further research. … The formula for price to earnings is: Price to Earnings Ratio = Share Price ÷ Earnings per Share (EPS) Or for Ocean Bio-Chem: P/E of 11.36 = $3.5 ÷ $0.31 (Based on the trailing twelve months to June 2019.) Is A High Price-to-Earnings Ratio Good? … All else being equal, it's better to pay a low price -- but as Warren Buffett said, 'It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price.' How Does Ocean Bio-Chem's P/E Ratio Compare To Its Peers?

Simply Wall St -

Do You Know About Ocean Bio-Chem, Inc.’s (NASDAQ:OBCI) ROCE?

The formula for calculating the return on capital employed is: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) Or for Ocean Bio-Chem: 0.12 = US$4.0m ÷ (US$37m - US$3.9m) (Based on the trailing twelve months to March 2019.) So, Ocean Bio-Chem has an ROCE of 12%. … Ocean Bio-Chem's Current Liabilities And Their Impact On Its ROCE Short term (or current) liabilities, are things like supplier invoices, overdrafts, or tax bills that need to be paid within 12 months. … The ROCE equation subtracts current liabilities from capital employed, so a company with a lot of current liabilities appears to have less capital employed, and a higher ROCE than otherwise.

Simply Wall St -

Does Ocean Bio-Chem, Inc.'s (NASDAQ:OBCI) CEO Pay Matter?

Check out our latest analysis for Ocean Bio-Chem How Does Peter Dornau's Compensation Compare With Similar Sized Companies? … Most shareholders would consider it a positive that Peter Dornau takes less total compensation than the CEOs of most similar size companies, leaving more for shareholders. … The graphic below shows how CEO compensation at Ocean Bio-Chem has changed from year to year.

Simply Wall St -

These 4 Measures Indicate That Ocean Bio-Chem (NASDAQ:OBCI) Is Using Debt Reasonably Well

NasdaqCM:OBCI Historical Debt, July 1st 2019 How Strong Is Ocean Bio-Chem's Balance Sheet? … Since Ocean Bio-Chem does have net debt, we think it is worthwhile for shareholders to keep an eye on the balance sheet, over time. … Over the last three years, Ocean Bio-Chem recorded negative free cash flow, in total.

Simply Wall St -

Is Ocean Bio-Chem, Inc.'s (NASDAQ:OBCI) ROE Of 11% Impressive?

The formula for return on equity is: Return on Equity = Net Profit ÷ Shareholders' Equity Or for Ocean Bio-Chem: 11% = US$3.0m ÷ US$28m (Based on the trailing twelve months to March 2019.) Most know that net profit is the total earnings after all expenses, but the concept of shareholders' equity is a little more complicated. … Does Ocean Bio-Chem Have A Good Return On Equity? … Ocean Bio-Chem's Debt And Its 11% ROE Although Ocean Bio-Chem does use debt, its debt to equity ratio of 0.18 is still low.

Simply Wall St -

Is Now The Time To Put Ocean Bio-Chem (NASDAQ:OBCI) On Your Watchlist?

In the age of tech-stock blue-sky investing, my choice may seem old fashioned; I still prefer profitable companies like Ocean Bio-Chem (NASDAQ:OBCI). … Check out our latest analysis for Ocean Bio-Chem How Quickly Is Ocean Bio-Chem Increasing Earnings Per Share? … For growth investors like me, Ocean Bio-Chem's raw rate of earnings growth is a beacon in the night.

Simply Wall St -

Does Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Have A Good P/E Ratio?

We'll apply a basic P/E ratio analysis to Ocean Bio-Chem, Inc.'s (NASDAQ:OBCI), to help you decide if the stock is worth further research. … Looking at earnings over the last twelve months, Ocean Bio-Chem has a P/E ratio of 9.96. … Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS)

Simply Wall St -

Does Ocean Bio-Chem, Inc.'s (NASDAQ:OBCI) CEO Pay Reflect Performance?

This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. … How Does Peter Dornau's Compensation Compare With Similar Sized Companies. … has a market cap of US$29m, and is paying total annual CEO compensation of US$300k.

Simply Wall St -

Does Ocean Bio-Chem, Inc.’s (NASDAQ:OBCI) ROCE Reflect Well On The Business?

In particular, we'll consider its Return On Capital Employed (ROCE), as that can give us insight into how profitably the company is able to employ capital in its business. … Understanding Return On Capital Employed (ROCE). … ROCE measures the 'return' (pre-tax profit) a company generates from capital employed in its business.

Simply Wall St -

How Much Of Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Do Insiders Own?

If you want to know who really controls Ocean Bio-Chem, Inc. … With a market capitalization of US$32m, Ocean Bio-Chem is a small cap stock, so it might not be well known by many institutional investors. … See our latest analysis for Ocean Bio-Chem

Simply Wall St -

OBCI Company Info

Description

Ocean Bio-Chem, Inc. manufactures, markets, and distributes appearance, performance, and maintenance products for the marine, automotive, power sports, recreational vehicle, and outdoor power equipment markets in the United States and Canada. The company offers marine products, including polishes, cleaners, protectants, waxes, enzyme fuel treatments, private label products, motor and teak oils, boat washes, vinyl and teak cleaners, bilge and hull cleaners, silicone and polyurethane sealants, polysulfide sealants, gasket materials, lubricants, antifouling additives, and anti-freeze coolants; and brushes, brush handles, tie-downs, and other related accessories. It also manufactures automotive products, such as fuel treatments for gas and diesel engines, motor oils, greases, and related items; anti-freeze and windshield washes; and automotive polishes, cleaners, and other items. In addition, the company offers fuel treatment and other specialty products to the recreational vehicle market; solutions to various problems associated with E-10 fuel; and other specialty recreational vehicle/power sports products, including cleaners, polishes, detergents, fabric cleaners and protectors, silicone sealants, waterproofers, gasket materials, degreasers, vinyl cleaners and protectors, toilet treatment fluids, and anti-freeze/coolants. Further, it provides solutions to rectify operating engine problems in commercial lawn, and other home and garden power equipment; and blends and packages chemical formulations, as well as manufactures PVC and HDPE blow molded bottles. Additionally, the company offers disinfectants and air care products for deodorizing, as well as products to eliminate mold and mildew; and PVC and HDPE blow molded bottles. Ocean Bio-Chem, Inc. sells its products under the Star Tron, Performacide, and Star brite brands through retailers and online retailers, as well as to distributors. The company was founded in 1973 and is headquartered in Fort Lauderdale, Florida.

Details
Name: Ocean Bio-Chem, Inc.
OBCI
Exchange: NasdaqCM
Founded: 1973
$43,083,358
9,448,105
Website: http://www.oceanbiochem.com
Address: Ocean Bio-Chem, Inc.
4041 SW 47th Avenue,
Fort Lauderdale,
Florida, 33314,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqCM OBCI Common Stock Nasdaq Capital Market US USD 27. Mar 1981
DB OBC Common Stock Deutsche Boerse AG DE EUR 27. Mar 1981
Number of employees
Current staff
Staff numbers
152
Ocean Bio-Chem employees.
Industry
Household Products
Household
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/03/31 01:28
End of day share price update: 2020/03/30 00:00
Last estimates confirmation: 2019/03/29
Last earnings filing: 2019/11/14
Last earnings reported: 2019/09/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.